News
Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.
Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.
Filter by:
10th May 2018
Blog DMPK Therapeutic Areas
Understanding and predicting brain penetration for CNS-targeted drugs
8th April 2018
News
British Toxicology Society Annual Meeting (Newcastle, 16-18 of April)
26th February 2018
Awards News
Discovery Building, Sygnature Discovery’s HQ, nominated for RICS Awards 2018, East Midlands
20th February 2018
Drug Discovery Therapeutic Areas
Sygnature Discovery’s medicinal chemists design improved agents against RSV infection
7th February 2018
News
Sygnature Discovery to co-host Predictive Toxicology in Discovery DMPK conference
17th January 2018
News
Sygnature Discovery team in the final of the 5th National RSC/SCI Retrosynthesis Competition
19th December 2017
News
Sygnature Discovery featured on BBC News as a UK life science success
11th October 2017
News
Sygnature Discovery at BioJapan 2017 – Participating in UK Department of International Trade Mission
9th October 2017
News
Phoenix Equity Partners announces investment in Sygnature Discovery
6th October 2017
News
Sygnature Discovery wins Best Contract Research Organisation Award at OBN Awards 2017
5th October 2017
News
Sygnature Discovery focuses on US expansion with the Appointment of Dr Bruce Sargent
3rd October 2017
News
Sygnature Discovery showcases its Bioscience expertise at ELRIG Drug Discovery 2017